“Interleukin 22 (IL-22) As Biomarker For Rheumatoid Arthritis In Iraqi Population”. Journal of Pharmaceutical Negative Results (October 4, 2022): 209–212. Accessed June 6, 2026. https://www.pnrjournal.com/index.php/home/article/view/1220.